HIV-specific immune dysregulation and atherosclerosis (Q38013681)

27 August 2017

HIV-specific immune dysregulation and atherosclerosis (English)

1 reference

27 August 2017

1 reference

1

Markella V Zanni

1 reference

27 August 2017

Steven K Grinspoon

2

1 reference

27 August 2017

1 September 2012

1 reference

27 August 2017

Current HIV/AIDS reports

1 reference

27 August 2017

9

1 reference

27 August 2017

3

1 reference

27 August 2017

200-205

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-012-0123-y

27 August 2017

0 references

cites work

Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Survival of persons with and without HIV infection in Denmark, 1995-2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Causes of death among persons with AIDS in the era of highly active antiretroviral therapy: New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Increased cardiovascular disease risk indices in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Combination antiretroviral therapy and the risk of myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

CD4+ count-guided interruption of antiretroviral treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Human immunodeficiency virus per se exerts atherogenic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Role of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Innate and adaptive immunity in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Therapeutic targeting of chemokine interactions in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Progress and challenges in translating the biology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV-1 Tat promotes monocyte chemoattractant protein-1 secretion followed by transmigration of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV-1 Tat protein-induced VCAM-1 expression in human pulmonary artery endothelial cells and its signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV-1 Tat increases the adhesion of monocytes and T-cells to the endothelium in vitro and in vivo: implications for AIDS-associated vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV-1 Tat induces microvascular endothelial apoptosis through caspase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Effects of HIV-1 infection in vitro on transendothelial migration by monocytes and monocyte-derived macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Human immunodeficiency virus type 1 (HIV-1) Nef activates STAT3 in primary human monocyte/macrophages through the release of soluble factors: involvement of Nef domains interacting with the cell endocytotic machinery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV-1 Nef induces the release of inflammatory factors from human monocyte/macrophages: involvement of Nef endocytotic signals and NF-kappa B activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

T helper type 1 lymphocytes drive inflammation in human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

CD14lowCD16high: a cytokine-producing monocyte subset which expands during human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Increased CD11/CD18 expression on the peripheral blood leucocytes of patients with HIV disease: relationship to disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Relationship between T cell activation and CD4+ T cell count in HIV-seropositive individuals with undetectable plasma HIV RNA levels in the absence of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Endothelial activation markers are linked to HIV status and are independent of antiretroviral therapy and lipoatrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Aortic stiffness in untreated adult patients with human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Untreated HIV infection and large and small artery elasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Impact of HIV infection and HAART on serum lipids in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Cardiovascular risk and body-fat abnormalities in HIV-infected adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Human immunodeficiency virus impairs reverse cholesterol transport from macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV infection and high density lipoprotein metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

HIV-1 infected patients with suppressed plasma viremia on treatment have pro-inflammatory HDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Inflammation predicts changes in high-density lipoprotein particles and apolipoprotein A1 following initiation of antiretroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Paraoxonase-1 gene haplotypes are associated with metabolic disturbances, atherosclerosis, and immunologic outcome in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

A genome-wide association study of carotid atherosclerosis in HIV-infected men

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Anti-inflammatory treatment with pentoxifylline improves HIV-related endothelial dysfunction: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Cardiovascular Risks of Antiretroviral Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11904-012-0123-Y

Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome

21 January 2018

1 reference

12 December 2020

The human immunodeficiency virus-1 Tat protein activates human umbilical vein endothelial cell E-selectin expression via an NF-kappa B-dependent mechanism

1 reference

12 December 2020

Apoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120

1 reference

12 December 2020

CD14+CD16+ monocytes in coronary artery disease and their relationship to serum TNF-alpha levels

1 reference

12 December 2020

HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction

1 reference

12 December 2020

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

1 reference

12 December 2020

HIV envelope protein gp120-triggered CD4+ T-cell adhesion to vascular endothelium is regulated via CD4 and CXCR4 receptors

1 reference

12 December 2020

Concentration of circulating oxidized LDL in HIV-infected patients treated with antiretroviral agents: relation to HIV-related lipodystrophy

1 reference

12 December 2020

Human immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cells

1 reference

12 December 2020

Productive HIV-1 infection of human vascular endothelial cells requires cell proliferation and is stimulated by combined treatment with interleukin-1 beta plus tumor necrosis factor-alpha

1 reference

12 December 2020

10.1007/S11904-012-0123-Y

Identifiers

DOI

1 reference

27 August 2017

1 reference

PubMed ID

22638983